[e-drug] Indicators for documenting injection practices

[Kirsten Myhr <myhr@online.no>]

E-drug: Indicators for documenting injection practices
-------------------------------------------------------------------------

[Crossposted from SIGN. KM]

KEY INDICATORS FOR COMMENT: GLOBAL DATABASE ON INJECTION PRACTICES

Yvan Hutin, SIGN Secretariat, has kindly posted this draft of a set of key
indicators for a "Global Database of Injection Practices".

* Comments and suggestions to: hutiny@who.int, sign@acithn,uq,edu.au
___________________________________________________________________________

Date: Wed, 20 Jun 2001

We are currently working on a set of key indicators that would constitute a
"Global Database of Injection Practices" to document injection practices,
their determinants, and their consequences worldwide.

I attach the draft one-page set of indicators. This page would come
ultimately be linked with the rapid assessment and response guide that 
would
be the tool to use to collect the information needed.

I would be happy to receive comments and suggestions from the SIGN 
participants.

Best regards,

Dr Yvan Hutin
Medical Officer
Safe Injection Global Network (SIGN)
Blood Safety and Clinical Technology (BCT)
World Health Organization
20, Avenue Appia, Rm. M 22
CH- 1211 Geneva 27
Switzerland

Tel: +41 (22) 791 34 31 (direct)
Fax: +41 (22) 791 48 36
E-mail: hutiny@who.int

www.injectionsafety.org
___________________________________________________________________________

Draft 02 - 20 June 2001

PART I: QUANTITATIVE INDICATORS

PART I.A: INJECTION PRACTICES INDICATORS
Proportion of injections given with equipment re-used w/o sterilization %
Proportion of facilities with dirty sharps observed in unprotected
containers %
Proportion of facilities with dirty sharps in surrounding environments %
Annual incidence of needlestick injuries among healthcare providers /
person / year
Annual ratio of injection per capita	/ person /year
Proportion of therapeutic injections that are unnecessary %
Proportion of outpatients visits followed by an injection (EDM OT8) %
Proportion of injections administered by private lay healthcare workers %

PART I.B: DEMOGRAPHIC CHARACTERISTICS INDICATORS
Population count size Thousands
Live expectancy at birth Years
Live expectancy at 30 years: Years
Birth cohort: Thousands

PART I.C: ECONOMIC INDICATORS
Average price paid for an injection US$
Average retail price for a new, 2ml syringe of appropriate quality US$
Average cost of an outpatient visit US$
Average cost of a hospitalisation day US$
Proportion of the population in active work force %
Annual number of hospital days for patients with complicated cirrhosis Days
Annual number of hospital days for patients with symptomatic HIV/AIDS Days
Annual GNP per capita US$

PART I.D: EPIDEMIOLOGY OF BLOODBORNE PATHOGENS INDICATORS
Prevalence of hepatitis C virus (HCV) infection %
Prevalence of hepatitis B surface antigen HBsAg %
Prevalence of HIV infection %

PART I.E: KNOWLEDGE AND ATTITUDES INDICATORS
Proportion of the population aware of injection-associated HIV %
Proportion of the population preferring for injections for the treatment of
fever 	%
Proportion of providers reporting patients' preference for injections %
Proportion of providers aware of injection-associated HCV infection %

PART I.F: IMMUNIZATION COVERAGE INDICATORS
Diphtheria Pertussis Tetanus (DPT) 3 coverage %
Hepatitis B Vaccine (HBV) 3 coverage %

___________________________________________________
Visit the SIGN website at: www.injectionsafety.org

SIGN files are available on the web at:  ftp://acithn.uq.edu.au/signfiles/
SIGNpost archives: ftp://acithn.uq.edu.au/signfiles/SIGNpostArchives
Join SIGN at: http://www.injectionsafety.org/html/joining.html

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.